Swiss stocks - Factors to watch on January 12

Interroll Holding AG

12/01/2021 05:59

ZURICH/BERLIN, Jan 12 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:

    CORONAVIRUS
    Swiss Health Minister Alain Berset said on Monday he expects
Switzerland's drugs regulator swissmedic to approve Moderna
Inc's MRNA.O COVID-19 vaccine "very soon", suggesting a wait of
just days, not weeks.  urn:newsml:reuters.com:*:nFWN2JM0ZP
    The World Health Organization hopes to be able to launch
COVID-19 vaccines in poor and lower middle-income countries in
February through its COVAX programme, WHO Senior Adviser Bruce
Aylward said on Monday.  urn:newsml:reuters.com:*:nG8N2D202M
    
    SIKA  SIKA.S  
    Swiss construction chemicals maker Sika on Tuesday reported
a 2.9% decline in annual reported sales as the Swiss franc rose
in value during 2020 against most currencies, as investors
sought safe-haven assets during the COVID-19 pandemic.
 urn:newsml:reuters.com:*:nL4N2JN130
    
    UBS  UBSG.S 
    UBS has hired Standard Chartered banker Axel Granger as its
Southeast head of M&A and financial sponsors, two people with
direct knowledge of the matter said on Tuesday.  urn:newsml:reuters.com:*:nL1N2JN043
    
    NOVARTIS  NOVN.S 
    China-based biotechnology company BeiGene Ltd  6160.HK  said
on Monday it will partner with Swiss firm Novartis to develop,
manufacture and commercialize its cancer drug tislelizumab.
 urn:newsml:reuters.com:*:nL1N2JN023
      
    COMPANY STATEMENTS
    * Interroll  INRN.S  appointed Ingo Steinkrueger as a new
CEO.
    * ADDEX  ADXN.S  said it had successfully completed an $11.5
million capital increase, including full exercise of
underwriter's option to purchase additional securities.
    * Lonza  LONN.S  said on Monday it has begun manufacturing
ingredients for Moderna Inc's  MRNA.O  COVID-19 vaccine from the
first of three new Swiss production lines and expects the
initial batch to be ready by month's end.  urn:newsml:reuters.com:*:nL8N2JM5WK
    * HIAG Immobilien  HIAG.S  launched a joint venture with
Aventron for production of solar power.
    
    
    ANALYSTS' VIEWS
    * SWISS RE AG  SRENH.S : CREDIT SUISSE RAISES TARGET PRICE
TO CHF 90 FROM CHF 81
    * TEMENOS AG  TEMN.S : CREDIT SUISSE CUTS TO UNDERPERFORM
FROM NEUTRAL, TEMENOS AG TEMN.S: CREDIT SUISSE CUTS TARGET PRICE
TO CHF 97 FROM CHF 112
    * LEONTEQ AG  LEON.S : CREDIT SUISSE CUTS TARGET PRICE TO
CHF 39 FROM CHF 42
    * IDORSIA LTD  IDIA.S : CREDIT SUISSE RAISES TARGET PRICE TO
CHF 36 FROM CHF 34
    * FLUGHAFEN ZUERICH AG  FHZN.S : CREDIT SUISSE RAISES TARGET
PRICE TO CHF 145 FROM CHF 120
    
    ECONOMY
    No major economic data scheduled.
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))